Mitotic kinesin inhibitors
The present invention relates to compounds that are useful for treating cellular proliferative diseases, for treating disorders mediated, at least in part, by KSP, and for inhibiting KSP. The invention also related to pharmaceutical compositions comprising such compounds, methods of treating cancer by the administration of such compositions, and processes for the preparation of the compounds. Compounds of the invention have the following formula:
Novartis Vaccines and Diagnostics, Inc.
C A C A A A A A
C07D A61P C07D A61P A61P A61P A61P A61P
inventional inventional inventional inventional inventional inventional inventional inventional
Liana Weibo Ryan
Lagniton Wang Constantine